Emerald Advisers »

Longboard Pharmaceuticals In shares owned by Emerald Advisers

Quarter-by-quarter ownership of Longboard Pharmaceuticals In (LBPH) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Longboard Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Longboard Pharmaceuticals In held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Longboard Pharmaceuticals In by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $23M 684k 33.33
2024-06-30 $6.2M 229k 27.03

More positions owned by Emerald Advisers

Ftai Aviation (FTAI)
Freshpet (FRPT)
Carpenter Technology Corporation (CRS)
Varonis Sys (VRNS)
Insmed (INSM)
Q2 Holdings (QTWO)
Credo Technology Group Holding (CRDO)
RadNet (RDNT)
Brp Group (BWIN)
AeroVironment (AVAV)
Allegheny Technologies Incorporated (ATI)
Palomar Hldgs (PLMR)
Kratos Defense & Security Solutions (KTOS)
Impinj (PI)
Livanova Plc Ord (LIVN)

View all positions for Emerald Advisers

Top funds holding Longboard Pharmaceuticals In

RA Capital Management
Farallon Capital Management
Cormorant Asset Management
T. Rowe Price Associates
BlackRock
Vanguard Group
Viking Global Investors
Point72 Asset Management
Jennison Associates
State Street Corporation
Parkman Healthcare Partners
Emerald Advisers
Geode Capital Management
Jpmorgan Chase & Co
Driehaus Capital Management

View all funds holding Longboard Pharmaceuticals In